How much funding has Axogen raised?

Axogen has raised $192.3M in total funding, most recently a Growth Equity round.

Who are Axogen's investors?

Axogen's investors include Accuitive Medical Ventures, Cardinal Partners, De Novo Ventures, Springboard, Essex Woodlands Health Ventures.

Where is Axogen headquartered?

Axogen is headquartered in Alachua, Florida, United States.

Axogen

IPO

Peripheral Nerve Repair & Surgery Technologies

Public · Alachua, United States · Founded 2002 · $192.3M raised

Healthcare

Headquarters: Alachua, Florida
Employees: 501–1000
Founded: 2002
Business Model: B2B
Website: axogeninc.com

Total Funding: $192.3M
Last Round: $124.0M Growth EquityJan 2026
Rounds: 5
Type: Public

About

Axogen, Inc. is a medical technology company founded in 2002 and headquartered in Alachua, Florida. It is the only company solely focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen's product portfolio includes the Avance Nerve Graft and Axoguard Nerve Connector and Protector devices, with clinical data showing sensory and motor recovery in 87% of patients. The company is publicly traded on Nasdaq (AXGN).

Summary

Axogen is a Healthcare company based in Alachua, United States, founded in 2002. It has raised $192.3M in total across 5 rounds, most recently a $124.0M Growth Equity round in Jan 2026. Investors include Accuitive Medical Ventures, Cardinal Partners and De Novo Ventures.

LinkedIn X (Twitter)